tiprankstipranks
Advertisement
Advertisement

IMNM Stock Latest News

Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
The FlyLeerink says Tubulis deal highlights value of ADC platforms like Sutro’s
1d ago
GILD
IMNM
Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
PremiumRatings
Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
29d ago
IMNM
Immunome price target lowered to $30 from $32 at Lake Street
PremiumThe Fly
Immunome price target lowered to $30 from $32 at Lake Street
1M ago
IMNM
Immunome price target raised to $36 from $33 at Craig-Hallum
PremiumThe Fly
Immunome price target raised to $36 from $33 at Craig-Hallum
1M ago
IMNM
Immunome price target lowered to $30 from $33 at Stephens
PremiumThe Fly
Immunome price target lowered to $30 from $33 at Stephens
1M ago
IMNM
Immunome price target raised to $39 from $35 at JPMorgan
PremiumThe FlyImmunome price target raised to $39 from $35 at JPMorgan
1M ago
IMNM
Immunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
Premium
Ratings
Immunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
1M ago
IMNM
Immunome reports FY25 EPS ($2.43), consensus ($2.21)
Premium
The Fly
Immunome reports FY25 EPS ($2.43), consensus ($2.21)
1M ago
IMNM
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
PremiumRatings
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
2M ago
IMNM
Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls
2M ago
ON
ADI
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
PremiumRatings
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
2M ago
IMNM
Immunome initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Immunome initiated with a Buy at H.C. Wainwright
2M ago
IMNM
Immunome Announces Follow-On Public Offering Pricing
PremiumCompany AnnouncementsImmunome Announces Follow-On Public Offering Pricing
4M ago
8K
IMNM
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
Premium
The Fly
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
4M ago
PG
ABM
Immunome falls -7.2%
Premium
The Fly
Immunome falls -7.2%
4M ago
IMNM
Immunome 18.625M share Spot Secondary priced at $21.50
PremiumThe Fly
Immunome 18.625M share Spot Secondary priced at $21.50
4M ago
IMNM
Immunome price target raised to $32 from $22 at Lake Street
PremiumThe Fly
Immunome price target raised to $32 from $22 at Lake Street
4M ago
IMNM
Immunome price target raised to $40 from $18 at Evercore ISI
PremiumThe Fly
Immunome price target raised to $40 from $18 at Evercore ISI
4M ago
IMNM
Immunome price target raised to $35 from $25 at Guggenheim
PremiumThe Fly
Immunome price target raised to $35 from $25 at Guggenheim
4M ago
IMNM
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
PremiumMarket News3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
4M ago
IMNM
KYTX
Immunome offers to sell $400M in common stock
Premium
The Fly
Immunome offers to sell $400M in common stock
4M ago
IMNM
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
Premium
Ratings
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
4M ago
IMNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >